PHARMExcel | Top CRO in UK – 2025 | Life Sciences Review

The idea of stepping away from the standard CRO model, which is often driven by commercial returns, came from founder and CEO Yvanne Enever. During her time working with the clinical research team at University College London, she witnessed firsthand the lack of operational infrastructure researchers face when trying to move innovation forward. Earlier in her career, as a nurse and senior transplant practitioner within the UK National Health Service (NHS), she had already seen the other side of that equation – patients in urgent need of novel therapies. That dual perspective became the foundation for PHARMExcel.